Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
McGuff Pharmaceuticals
McGuff Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Ascor
Ascorbic acid
2017-10-02
2024-2033
Common cold
,
Constipation
,
Methemoglobinemia
,
Penetrating wounds
,
Tyrosinemias
,
Scurvy
,
Hypercholesterolemia
,
Hypophosphatemia
,
Hypertriglyceridemia
,
Peripheral vascular diseases
,
Dermatitis
,
Alcoholic neuropathy
,
Seizures
,
Vitamin a deficiency
,
Hypoparathyroidism
,
Inborn errors metabolism
,
Photosensitivity disorders
,
Thiamine deficiency
,
Folic acid deficiency
,
Rickets
,
Vitamin b 6 deficiency
,
Megaloblastic anemia
,
Vitamin b deficiency
,
Xerophthalmia
,
Wernicke encephalopathy
,
Beriberi
,
Night blindness
,
Riboflavin deficiency
,
Pellagra
,
Chronic kidney failure
,
Cardiovascular diseases
,
Psoriasis
,
Lung neoplasms
,
Crohn disease
,
Skin neoplasms
,
Familial hypophosphatemic rickets
,
Osteoporosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ascorbic acid
keratoconjunctivitis sicca
,
dry eye syndromes
,
healthy volunteers/patients
,
diabetic retinopathy
,
pigmentation
Aglatimagene besadenovec
glioblastoma
,
glioma
,
recurrence
,
renal cell carcinoma
,
colorectal neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
melanoma
,
kidney neoplasms
,
small cell carcinoma
,
neoplasms
,
castration-resistant prostatic neoplasms
,
neoplasm metastasis
,
adenocarcinoma
,
prostatic diseases
,
carcinoma
,
urogenital neoplasms
,
male genital neoplasms
,
neuroendocrine carcinoma
,
neoplasms by site
,
x-linked bulbo-spinal atrophy
,
glandular and epithelial neoplasms
,
male genital diseases
,
genital diseases
,
endometrial neoplasms
,
prostatic neoplasms
Bevifimod
peripheral arterial disease
,
intermittent claudication
,
peripheral vascular diseases
,
neoplasms
,
hypophosphatemic rickets
,
hemophilia b
,
pseudoxanthoma elasticum
,
genetic therapy
,
mucopolysaccharidosis iv
,
hemophilia a
,
lysosomal storage diseases
,
hematologic diseases
,
blood coagulation disorders
,
hemostatic disorders
,
inborn genetic diseases
,
hemorrhagic disorders
,
inherited blood coagulation disorders
,
coagulation protein disorders
,
phenylketonurias
Retinol
systemic lupus erythematosus
,
cutaneous lupus erythematosus
,
psoriasis
,
skin diseases
,
dermatitis
,
hand dermatoses
,
eczema
Taxane
ovarian neoplasms
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use